Article

CURE® Magazine Named 2017 Friend of the Foundation Award by Oncology Nursing Society Foundation

(Cranbury, NJ — May 4, 2017) - CURE® Magazine, the leading consumer digital and print media enterprise focused entirely on patients with cancer, proudly announces it has been awarded the 2017 Oncology Nursing Society (ONS) Foundation Friend of the Foundation award during the 42nd Annual ONS Annual Congress in Denver, Colorado. In addition, 4,000 oncology nurses were present.

Accepting the award for CURE® Magazine, Michael J. Hennessy Jr. president of Michael J. Hennessy Associates, parent company of CURE® Magazine states, “It is a tremendous honor that CURE® Magazine has been recognized with winning this prestigious award — the Friend of the Foundation. This achievement is a true testament of the talent showed by the whole team and furthering our mission to provide valuable information to patients, caregivers and survivors.”

Headquartered in Pittsburgh, Pennsylvania, Oncology Nursing Society Foundation is the world’s largest professional oncology nursing association. ONS Foundation has provided more than $25 million to fund local and national oncology nursing education, research and leadership opportunities. Additionally, the ONS Annual Congress is being held in conjunction with CURE® Extraordinary Healer® award reception, which will take place at the Hyatt Regency Denver at 6:00pm tonight.

About CURE Media Group

CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry leading website, CUREtoday.com; innovative video programs, such as CURE Connections®; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers. CURE Media Group is part of the Cranbury, New Jersey-based Michael J. Hennessy Associates, Inc., family of businesses, which includes the acclaimed OncLive® (http://www.onclive.com) platform of resources for the practicing oncologist. For more information, visit http://www.curetoday.com or http://www.mjhassoc.com.

Cure Media Group Press Contacts: Theresa Burek/609-716-7777 ext. 811 tburek@mjhassoc.com

Photograph courtesy of Oncology Nursing Society

Related Videos
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
1 expert is featured in this series.
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
1 expert is featured in this series.
Related Content
Illustration of lungs.
January 14th 2025

FDA Grants Priority Review to Sunvozertinib for EGFR Exon20+ NSCLC

Alex Biese
The Food and Drug Administration has accepted and granted priority review to a new drug application for sunvozertinib.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
An image of a patient and doctor holding hands.
January 14th 2025

The Pros and Cons of Seeking a Second Opinion In Cancer Treatment

Dr. Mohammad Jahanzeb
An expert explains the importance of getting a second opinion during a cancer journey.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of bladder.
January 13th 2025

Sasanlimab Improves Event-Free Survival for Some With Bladder Cancer

Alex Biese
The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.
Image of doctor and patient holding hands.
January 13th 2025

Hackensack University Medical Center Launches Educational Website for People with Kidney Cancer

John Theurer Cancer Center
Members of the Department of Urology at Hackensack University Medical Center have launched the Kidney Cancer Resource Center.